论文部分内容阅读
目的探讨TASC-C、D型慢性主髂动脉病变腔内介入治疗的操作成功率、安全性和近期通畅率。方法2005年4月至2006年12月,上海交通大学医学院附属仁济医院血管外科采用血管腔内介入方法治疗TASC-C、D型慢性主髂动脉病变病人14例,其中2例接受了二期远端流出道重建。结果无围手术期死亡。血管腔内介入治疗成功率为93.7%,并发症发生率为7.1%。随访2~20个月(平均6.5个月),病人症状无加重或复发。结论血管腔内介入治疗TASC-C、D型慢性主髂动脉病变具有较高的操作成功率,围手术期并发症少,近期效果确切,其长期疗效尚须进一步随访观察。
Objective To investigate the operative success rate, safety and short-term patency rate of interventional treatment of TASC-C and D-type chronic primary iliac artery disease. Methods From April 2005 to December 2006, 14 cases of TASC-C and D-type chronic primary iliac artery disease were treated with endovascular interventional therapy in the Department of Vascular Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Two of them received two Remote outflow tract reconstruction. Results no perioperative deaths. Endovascular interventional treatment success rate was 93.7%, the complication rate was 7.1%. All cases were followed up for 2 to 20 months (mean, 6.5 months). No symptoms or recurrence were found. Conclusion Endovascular treatment of TASC-C, D-type chronic primary iliac artery disease has a high success rate of operation, less perioperative complications, the exact effect of the near future, its long-term efficacy needs further follow-up observation.